Publication: 3485

Publication: 3485

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 39 (22) 2486-2496

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:: 10

Parents:: 3075
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233290, P30CA008748, UG1CA233234, UG1CA233324, UG1CA233327, UG1CA233331, UG1CA233339, UG1CA189819, UG1CA189858, U10CA180820 (ECOG-ACRIN), U10CA180819 (SWOG)

Corr. Author:
Authors:: Jonathan E. Rosenberg Karla A. Ballman Susan Halabi Pamela J. Atherton Amir Mortazavi Christopher Sweeney Walter M. Stadler Benjamin A. Teply Joel Picus Scott T. Tagawa Sreedhar Katragadda Daniel Vaena Jamal Misleh Christopher Hoimes Elizabeth R. Plimack Thomas W. Flaig Robert Dreicer Dean Bajorin Olwen Hahn Eric J. Small Michael J. Morris

Networks:: CA824, CHRISTIANA, IA018, LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-OH007, NE003, NY018, SCOR, VA009

Study: CALGB-90601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: ORIGINAL REPORTS, Genitourinary Cancer